Market Overview

Big Data Investments in the Healthcare & Pharmaceutical Industry Will Account for Nearly $4.7 Billion in 2018 Alone

Share:

Big Data Investments in the Healthcare & Pharmaceutical Industry Will Account for Nearly $4.7 Billion in 2018 Alone

PR Newswire

DUBLIN, July 30, 2018 /PRNewswire/ --

The "Big Data in the Healthcare & Pharmaceutical Industry: 2018 - 2030 - Opportunities, Challenges, Strategies & Forecasts" report from SNS Telecom & IT has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Big Data originally emerged as a term to describe datasets whose size is beyond the ability of traditional databases to capture, store, manage and analyze. However, the scope of the term has significantly expanded over the years. Big Data not only refers to the data itself but also a set of technologies that capture, store, manage and analyze large and variable collections of data, to solve complex problems.

Amid the proliferation of real-time and historical data from sources such as connected devices, web, social media, sensors, log files and transactional applications, Big Data is rapidly gaining traction from a diverse range of vertical sectors. The healthcare and pharmaceutical industry is no exception to this trend, where Big Data has found a host of applications ranging from drug discovery and precision medicine to clinical decision support and population health management.

This research estimates that Big Data investments in the healthcare and pharmaceutical industry will account for nearly $4.7 Billion in 2018 alone. Led by a plethora of business opportunities for healthcare providers, insurers, payers, government agencies, pharmaceutical companies and other stakeholders, these investments are further expected to grow at a CAGR of approximately 12% over the next three years.

The report presents an in-depth assessment of Big Data in the healthcare and pharmaceutical industry including key market drivers, challenges, investment potential, application areas, use cases, future roadmap, value chain, case studies, vendor profiles and strategies.

The report also presents market size forecasts for Big Data hardware, software and professional services investments from 2018 through to 2030. The forecasts are segmented for 8 horizontal submarkets, 5 application areas, 37 use cases, 6 regions and 35 countries.

Key Findings

  • In 2018, Big Data vendors will pocket nearly $4.7 Billion from hardware, software and professional services revenues in the healthcare and pharmaceutical industry. These investments are further expected to grow at a CAGR of approximately 12% over the next three years, eventually accounting for more than $7 Billion by the end of 2021.
  • Big Data and advanced analytics are driving a paradigm shift in the healthcare and pharmaceutical industry with multiple innovations ranging from precision medicine and digital therapeutics to the adoption of accountable and value-based care models.
  • Drug developers are making substantial investments in Big Data and artificial intelligence-driven drug discovery platforms to shorten the process of successfully discovering promising compounds. In addition, Big Data technologies are increasingly being utilized to streamline clinical trials, enabling biopharmaceutical companies to significantly lower costs and accelerate productive trials.
  • The growing adoption of Big Data technologies has also brought about an array of benefits for hospitals and other healthcare facilities. Based on feedback from healthcare providers worldwide, these include but are not limited to cost savings in the range of 20-30%, an increase in patient access to services by more than 35%, growth in revenue by up to 30%, a reduction in emergency room visits by 10%, a drop in patient wait times by 30-60%, improvements in outcomes by as much as 20%, a 10-50% decline in mortality rates for conditions such as heart failure, and a reduction in the occurrence of hospital acquired and surgical site infections by nearly 60%.

Key Topics Covered

Chapter 1: Introduction
1.1 Executive Summary
1.2 Topics Covered
1.3 Forecast Segmentation
1.4 Key Questions Answered
1.5 Key Findings
1.6 Methodology
1.7 Target Audience
1.8 Companies & Organizations Mentioned

Chapter 2: An Overview of Big Data
2.1 What is Big Data?
2.2 Key Approaches to Big Data Processing
2.2.1 Hadoop
2.2.2 NoSQL
2.2.3 MPAD (Massively Parallel Analytic Databases)
2.2.4 In-Memory Processing
2.2.5 Stream Processing Technologies
2.2.6 Spark
2.2.7 Other Databases & Analytic Technologies
2.3 Key Characteristics of Big Data
2.3.1 Volume
2.3.2 Velocity
2.3.3 Variety
2.3.4 Value
2.4 Market Growth Drivers
2.4.1 Awareness of Benefits
2.4.2 Maturation of Big Data Platforms
2.4.3 Continued Investments by Web Giants, Governments & Enterprises
2.4.4 Growth of Data Volume, Velocity & Variety
2.4.5 Vendor Commitments & Partnerships
2.4.6 Technology Trends Lowering Entry Barriers
2.5 Market Barriers
2.5.1 Lack of Analytic Specialists
2.5.2 Uncertain Big Data Strategies
2.5.3 Organizational Resistance to Big Data Adoption
2.5.4 Technical Challenges: Scalability & Maintenance
2.5.5 Security & Privacy Concerns

Chapter 3: Big Data Analytics
3.1 What are Big Data Analytics?
3.2 The Importance of Analytics
3.3 Reactive vs. Proactive Analytics
3.4 Customer vs. Operational Analytics
3.5 Technology & Implementation Approaches
3.5.1 Grid Computing
3.5.2 In-Database Processing
3.5.3 In-Memory Analytics
3.5.4 Machine Learning & Data Mining
3.5.5 Predictive Analytics
3.5.6 NLP (Natural Language Processing)
3.5.7 Text Analytics
3.5.8 Visual Analytics
3.5.9 Graph Analytics
3.5.10 Social Media, IT & Telco Network Analytics

Chapter 4: Business Case & Applications in the Healthcare & Pharmaceutical Industry
4.1 Overview & Investment Potential
4.2 Industry Specific Market Growth Drivers
4.3 Industry Specific Market Barriers
4.4 Key Applications
4.4.1 Pharmaceutical & Medical Products
4.4.1.1 Drug Discovery, Design & Development
4.4.1.2 Medical Product Design & Development
4.4.1.3 Clinical Development & Trials
4.4.1.4 Precision Medicine & Genomics
4.4.1.5 Manufacturing & Supply Chain Management
4.4.1.6 Post-Market Surveillance & Pharmacovigilance
4.4.1.7 Medical Product Fault Monitoring
4.4.2 Core Healthcare Operations
4.4.2.1 Clinical Decision Support
4.4.2.2 Care Coordination & Delivery Management
4.4.2.3 CER (Comparative Effectiveness Research) & Observational Evidence
4.4.2.4 Personalized Healthcare & Targeted Treatments
4.4.2.5 Data-Driven Preventive Care & Health Interventions
4.4.2.6 Surgical Practice & Complex Medical Procedures
4.4.2.7 Pathology, Medical Imaging & Other Medical Tests
4.4.2.8 Proactive & Remote Patient Monitoring
4.4.2.9 Predictive Maintenance of Medical Equipment
4.4.2.10 Pharmacy Services
4.4.3 Healthcare Support, Awareness & Disease Prevention
4.4.3.1 Self-Care & Lifestyle Support
4.4.3.2 Digital Therapeutics
4.4.3.3 Medication Adherence & Management
4.4.3.4 Vaccine Development & Promotion
4.4.3.5 Population Health Management
4.4.3.6 Connected Health Communities & Medical Knowledge Dissemination
4.4.3.7 Epidemiology & Disease Surveillance
4.4.3.8 Health Policy Decision Making
4.4.3.9 Controlling Substance Abuse & Addiction
4.4.3.10 Increasing Awareness & Accessible Healthcare
4.4.4 Health Insurance & Payer Services
4.4.4.1 Health Insurance Claims Processing & Management
4.4.4.2 Fraud & Abuse Prevention
4.4.4.3 Proactive Patient Engagement
4.4.4.4 Accountable & Value-Based Care
4.4.4.5 Data-Driven Health Insurance Premiums
4.4.5 Marketing, Sales & Other Applications
4.4.5.1 Marketing & Sales
4.4.5.2 Administrative & Customer Services
4.4.5.3 Finance & Risk Management
4.4.5.4 Healthcare Data Monetization
4.4.5.5 Other Applications

Chapter 5: Healthcare & Pharmaceutical Industry Case Studies
5.1 Pharmaceutical & Medical Device Companies
5.1.1 AbbVie: Designing & Implementing Clinical Trials with Big Data
5.1.2 AstraZeneca: Analytics-Driven Drug Development with Big Data
5.1.3 Bayer: Accelerating Clinical Trials with Big Data
5.1.4 BMS (Bristol-Myers Squibb): Driving Clinical Discovery with Big Data
5.1.5 GSK (GlaxoSmithKline): Increasing Success Rates in Drug Discovery with Big Data
5.1.6 Johnson & Johnson: Intelligent Pharmaceutical Marketing with Big Data
5.1.7 Medtronic: Facilitating Predictive Care with Big Data
5.1.8 Merck & Co.: Optimizing Vaccine Manufacturing with Big Data
5.1.9 Merck KGaA: Discovering Drugs Faster with Big Data
5.1.10 Novartis: Digitizing Healthcare with Big Data
5.1.11 Pfizer: Developing Effective and Targeted Therapies with Big Data
5.1.12 Roche: Personalizing Healthcare with Big Data
5.1.13 Sanofi: Proactive Diabetes Care with Big Data
5.2 Healthcare Providers, Insurers & Payers
5.2.1 Aetna: Predicting & Improving Health with Big Data
5.2.2 Ambulance Victoria: Improving Patient Survival Rates with Big Data
5.2.3 Bangkok Hospital Group: Transforming the Patient Experience with Big Data
5.2.4 Cigna: Streamlining Health Insurance Claims with Big Data
5.2.5 Gold Coast Health: Reducing Hospital Waiting Times with Big Data
5.2.6 IU Health (Indiana University Health): Preventing Hospital-Acquired Infections with Big Data
5.2.7 Moorfields Eye Hospital: Diagnosing Eye Diseases with Big Data
5.2.8 MSQC (Michigan Surgical Quality Collaborative): Surgical Quality Improvement with Big Data
5.2.9 NCCS (National Cancer Centre Singapore): Advancing Cancer Treatment with Big Data
5.2.10 NHS Scotland: Improving Outcomes with Big Data
5.2.11 Seattle Children's Hospital: Enabling Faster & Accurate Diagnosis with Big Data
5.2.12 UnitedHealth Group: Enhancing Patient Care & Value with Big Data
5.2.13 VHA (Veterans Health Administration): Streamlining Healthcare Delivery with Big Data
5.3 Other Stakeholders
5.3.1 Amino: Healthcare Transparency with Big Data
5.3.2 Atomwise: Improving Drug Discovery with Big Data
5.3.3 CosmosID: Advancing Microbial Genomics with Big Data
5.3.4 Deep Genomics: Discovering Novel Oligonucleotide Therapies with Big Data
5.3.5 Desktop Genetics: Facilitating Genome Editing with Big Data
5.3.6 Express Scripts: Improving Medication Adherence with Big Data
5.3.7 Faros Healthcare: Enhancing Clinical Decision Making with Big Data
5.3.8 Genomics England: Developing the World's First Genomics Medicine Service with Big Data
5.3.9 Ginger.io: Improving Mental Wellbeing with Big Data
5.3.10 Illumina: Enabling Precision Medicine with Big Data
5.3.11 INDS (National Institute of Health Data, France): Population Health Management with Big Data
5.3.12 MolecularMatch: Advancing the Clinical Utility of Genomics with Big Data
5.3.13 Proteus Digital Health: Pioneering Digital Medicine with Big Data
5.3.14 Royal Philips: Enhancing Workflows in ICUs (Intensive Care Units) with Big Data
5.3.15 Sickweather: Sickness Forecasting & Mapping with Big Data
5.3.16 Sproxil: Fighting Counterfeit Drugs with Big Data

Chapter 6: Future Roadmap & Value Chain
6.1 Future Roadmap
6.1.1 Pre-2020: Growing Investments in Real-Time & Predictive Health Analytics
6.1.2 2020 - 2025: Data-Driven Advances in Drug Discovery & Precision Medicine
6.1.3 2025 - 2030: Moving Beyond National-Level Population Health Management
6.2 The Big Data Value Chain
6.2.1 Hardware Providers
6.2.1.1 Storage & Compute Infrastructure Providers
6.2.1.2 Networking Infrastructure Providers
6.2.2 Software Providers
6.2.2.1 Hadoop & Infrastructure Software Providers
6.2.2.2 SQL & NoSQL Providers
6.2.2.3 Analytic Platform & Application Software Providers
6.2.2.4 Cloud Platform Providers
6.2.3 Professional Services Providers
6.2.4 End-to-End Solution Providers
6.2.5 Healthcare & Pharmaceutical Industry

Chapter 7: Standardization & Regulatory Initiatives
7.1 ASF (Apache Software Foundation)
7.1.1 Management of Hadoop
7.1.2 Big Data Projects Beyond Hadoop
7.2 CSA (Cloud Security Alliance)
7.2.1 BDWG (Big Data Working Group)
7.3 CSCC (Cloud Standards Customer Council)
7.3.1 Big Data Working Group
7.4 DMG (Data Mining Group)
7.4.1 PMML (Predictive Model Markup Language) Working Group
7.4.2 PFA (Portable Format for Analytics) Working Group
7.5 IEEE (Institute of Electrical and Electronics Engineers)
7.5.1 Big Data Initiative
7.6 INCITS (InterNational Committee for Information Technology Standards)
7.6.1 Big Data Technical Committee
7.7 ISO (International Organization for Standardization)
7.7.1 ISO/IEC JTC 1/SC 32: Data Management and Interchange
7.7.2 ISO/IEC JTC 1/SC 38: Cloud Computing and Distributed Platforms
7.7.3 ISO/IEC JTC 1/SC 27: IT Security Techniques
7.7.4 ISO/IEC JTC 1/WG 9: Big Data
7.7.5 Collaborations with Other ISO Work Groups
7.8 ITU (International Telecommunication Union)
7.8.1 ITU-T Y.3600: Big Data - Cloud Computing Based Requirements and Capabilities
7.8.2 Other Deliverables Through SG (Study Group) 13 on Future Networks
7.8.3 Other Relevant Work
7.9 Linux Foundation
7.9.1 ODPi (Open Ecosystem of Big Data)
7.10 NIST (National Institute of Standards and Technology)
7.10.1 NBD-PWG (NIST Big Data Public Working Group)
7.11 OASIS (Organization for the Advancement of Structured Information Standards)
7.11.1 Technical Committees
7.12 ODaF (Open Data Foundation)
7.12.1 Big Data Accessibility
7.13 ODCA (Open Data Center Alliance)
7.13.1 Work on Big Data
7.14 OGC (Open Geospatial Consortium)
7.14.1 Big Data DWG (Domain Working Group)
7.15 TM Forum
7.15.1 Big Data Analytics Strategic Program
7.16 TPC (Transaction Processing Performance Council)
7.16.1 TPC-BDWG (TPC Big Data Working Group)
7.17 W3C (World Wide Web Consortium)
7.17.1 Big Data Community Group
7.17.2 Open Government Community Group
7.18 Other Initiatives Relevant to the Healthcare & Pharmaceutical Industry
7.18.1 HIPAA (Health Insurance Portability and Accountability Act of 1996)
7.18.2 HITECH (Health Information Technology for Economic and Clinical Health) Act
7.18.3 European Union's GDPR (General Data Protection Regulation)
7.18.4 Australian Digital Health Agency
7.18.5 United Kingdom's ITK (Interoperability Toolkit)
7.18.6 Japan's SS-MIX (Standard Structured Medical Information eXchange)
7.18.7 Germany's xDT
7.18.8 France's DMP (Dossier Mdical Personnel)
7.18.9 HL7 (Health Level Seven) Specifications
7.18.10 IHE (Integrating the Healthcare Enterprise)
7.18.11 NCPDP (National Council for Prescription Drug Programs)
7.18.12 DICOM (Digital Imaging and Communications in Medicine)
7.18.13 eHealth Exchange
7.18.14 EDIFACT (Electronic Data Interchange For Administration, Commerce, and Transport)
7.18.15 HITRUST CSF (Common Security Framework)
7.18.16 DTA (Digital Therapeutics Alliance)
7.18.17 X12 & Others

Chapter 8: Market Sizing & Forecasts
8.1 Global Outlook for Big Data in the Healthcare & Pharmaceutical Industry
8.2 Hardware, Software & Professional Services Segmentation
8.3 Horizontal Submarket Segmentation
8.4 Hardware Submarkets
8.4.1 Storage and Compute Infrastructure
8.4.2 Networking Infrastructure
8.5 Software Submarkets
8.5.1 Hadoop & Infrastructure Software
8.5.2 SQL
8.5.3 NoSQL
8.5.4 Analytic Platforms & Applications
8.5.5 Cloud Platforms
8.6 Professional Services Submarket
8.6.1 Professional Services
8.7 Application Area Segmentation
8.7.1 Pharmaceutical & Medical Products
8.7.2 Core Healthcare Operations
8.7.3 Healthcare Support, Awareness & Disease Prevention
8.7.4 Health Insurance & Payer Services
8.7.5 Marketing, Sales & Other Applications
8.8 Use Case Segmentation
8.9 Pharmaceutical & Medical Products
8.9.1 Drug Discovery, Design & Development
8.9.2 Medical Product Design & Development
8.9.3 Clinical Development & Trials
8.9.4 Precision Medicine & Genomics
8.9.5 Manufacturing & Supply Chain Management
8.9.6 Post-Market Surveillance & Pharmacovigilance
8.9.7 Medical Product Fault Monitoring
8.10 Core Healthcare Operations
8.10.1 Clinical Decision Support
8.10.2 Care Coordination & Delivery Management
8.10.3 CER (Comparative Effectiveness Research) & Observational Evidence
8.10.4 Personalized Healthcare & Targeted Treatments
8.10.5 Data-Driven Preventive Care & Health Interventions
8.10.6 Surgical Practice & Complex Medical Procedures
8.10.7 Pathology, Medical Imaging & Other Medical Tests
8.10.8 Proactive & Remote Patient Monitoring
8.10.9 Predictive Maintenance of Medical Equipment
8.10.10 Pharmacy Services
8.11 Healthcare Support, Awareness & Disease Prevention
8.11.1 Self-Care & Lifestyle Support
8.11.2 Digital Therapeutics
8.11.3 Medication Adherence & Management
8.11.4 Vaccine Development & Promotion
8.11.5 Population Health Management
8.11.6 Connected Health Communities & Medical Knowledge Dissemination
8.11.7 Epidemiology & Disease Surveillance
8.11.8 Health Policy Decision Making
8.11.9 Controlling Substance Abuse & Addiction
8.11.10 Increasing Awareness & Accessible Healthcare
8.12 Health Insurance & Payer Services
8.12.1 Health Insurance Claims Processing & Management
8.12.2 Fraud & Abuse Prevention
8.12.3 Proactive Patient Engagement
8.12.4 Accountable & Value-Based Care
8.12.5 Data-Driven Health Insurance Premiums
8.13 Marketing, Sales & Other Application Use Cases
8.13.1 Marketing & Sales
8.13.2 Administrative & Customer Services
8.13.3 Finance & Risk Management
8.13.4 Healthcare Data Monetization
8.13.5 Other Use Cases
8.14 Regional Outlook
8.15 Asia Pacific
8.15.1 Country Level Segmentation
8.15.2 Australia
8.15.3 China
8.15.4 India
8.15.5 Indonesia
8.15.6 Japan
8.15.7 Malaysia
8.15.8 Pakistan
8.15.9 Philippines
8.15.10 Singapore
8.15.11 South Korea
8.15.12 Taiwan
8.15.13 Thailand
8.15.14 Rest of Asia Pacific
8.16 Eastern Europe
8.16.1 Country Level Segmentation
8.16.2 Czech Republic
8.16.3 Poland
8.16.4 Russia
8.16.5 Rest of Eastern Europe
8.17 Latin & Central America
8.17.1 Country Level Segmentation
8.17.2 Argentina
8.17.3 Brazil
8.17.4 Mexico
8.17.5 Rest of Latin & Central America
8.18 Middle East & Africa
8.18.1 Country Level Segmentation
8.18.2 Israel
8.18.3 Qatar
8.18.4 Saudi Arabia
8.18.5 South Africa
8.18.6 UAE
8.18.7 Rest of the Middle East & Africa
8.19 North America
8.19.1 Country Level Segmentation
8.19.2 Canada
8.19.3 USA
8.20 Western Europe
8.20.1 Country Level Segmentation
8.20.2 Denmark
8.20.3 Finland
8.20.4 France
8.20.5 Germany
8.20.6 Italy
8.20.7 Netherlands
8.20.8 Norway
8.20.9 Spain
8.20.10 Sweden
8.20.11 UK
8.20.12 Rest of Western Europe

Chapter 9: Vendor Landscape
9.1 1010data
9.2 Absolutdata
9.3 Accenture
9.4 Actian Corporation/HCL Technologies
9.5 Adaptive Insights
9.6 Adobe Systems
9.7 Advizor Solutions
9.8 AeroSpike
9.9 AFS Technologies
9.10 Alation
9.11 Algorithmia
9.12 Alluxio
9.13 ALTEN
9.14 Alteryx
9.15 AMD (Advanced Micro Devices)
9.16 Anaconda
9.17 Apixio
9.18 Arcadia Data
9.19 ARM
9.20 AtScale
9.21 Attivio
9.22 Attunity
9.23 Automated Insights
9.24 AVORA
9.25 AWS (Amazon Web Services)
9.26 Axiomatics
9.27 Ayasdi
9.28 BackOffice Associates
9.29 Basho Technologies
9.30 BCG (Boston Consulting Group)
9.31 Bedrock Data
9.32 BetterWorks
9.33 Big Panda
9.34 BigML
9.35 Bitam
9.36 Blue Medora
9.37 BlueData Software
9.38 BlueTalon
9.39 BMC Software
9.40 BOARD International
9.41 Booz Allen Hamilton
9.42 Boxever
9.43 CACI International
9.44 Cambridge Semantics
9.45 Capgemini
9.46 Cazena
9.47 Centrifuge Systems
9.48 CenturyLink
9.49 Chartio
9.50 Cisco Systems
9.51 Civis Analytics
9.52 ClearStory Data
9.53 Cloudability
9.54 Cloudera
9.55 Cloudian
9.56 Clustrix
9.57 CognitiveScale
9.58 Collibra
9.59 Concurrent Technology/Vecima Networks
9.60 Confluent
9.61 Contexti
9.62 Couchbase
9.63 Crate.io
9.64 Cray
9.65 Databricks
9.66 Dataiku
9.67 Datalytyx
9.68 Datameer
9.69 DataRobot
9.70 DataStax
9.71 Datawatch Corporation
9.72 DDN (DataDirect Networks)
9.73 Decisyon
9.74 Dell Technologies
9.75 Deloitte
9.76 Demandbase
9.77 Denodo Technologies
9.78 Dianomic Systems
9.79 Digital Reasoning Systems
9.80 Dimensional Insight
9.81 Dolphin Enterprise Solutions Corporation/Hanse Orga Group
9.82 Domino Data Lab
9.83 Domo
9.84 Dremio
9.85 DriveScale
9.86 Druva
9.87 Dundas Data Visualization
9.88 DXC Technology
9.89 Elastic
9.90 Engineering Group (Engineering Ingegneria Informatica)
9.91 EnterpriseDB Corporation
9.92 eQ Technologic
9.93 Ericsson
9.94 Erwin
9.95 EVO (Big Cloud Analytics)
9.96 EXASOL
9.97 EXL (ExlService Holdings)
9.98 Facebook
9.99 FICO (Fair Isaac Corporation)
9.100 Figure Eight
9.101 FogHorn Systems
9.102 Fractal Analytics
9.103 Franz
9.104 Fujitsu
9.105 Fuzzy Logix
9.106 Gainsight
9.107 GE (General Electric)
9.108 Glassbeam
9.109 GoodData Corporation
9.110 Google/Alphabet
9.111 Grakn Labs
9.112 Greenwave Systems
9.113 GridGain Systems
9.114 H2O.ai
9.115 HarperDB
9.116 Hedvig
9.117 Hitachi Vantara
9.118 Hortonworks
9.119 HPE (Hewlett Packard Enterprise)
9.120 Huawei
9.121 HVR
9.122 HyperScience
9.123 HyTrust
9.124 IBM Corporation
9.125 iDashboards
9.126 IDERA
9.127 Ignite Technologies
9.128 Imanis Data
9.129 Impetus Technologies
9.130 Incorta
9.131 InetSoft Technology Corporation
9.132 InfluxData
9.133 Infogix
9.134 Infor/Birst
9.135 Informatica
9.136 Information Builders
9.137 Infosys
9.138 Infoworks
9.139 Insightsoftware.com
9.140 InsightSquared
9.141 Intel Corporation
9.142 Interana
9.143 InterSystems Corporation
9.144 Jedox
9.145 Jethro
9.146 Jinfonet Software
9.147 Juniper Networks
9.148 KALEAO
9.149 Keen IO
9.150 Keyrus
9.151 Kinetica
9.152 KNIME
9.153 Kognitio
9.154 Kyvos Insights
9.155 LeanXcale
9.156 Lexalytics
9.157 Lexmark International
9.158 Lightbend
9.159 Logi Analytics
9.160 Logical Clocks
9.161 Longview Solutions/Tidemark
9.162 Looker Data Sciences
9.163 LucidWorks
9.164 Luminoso Technologies
9.165 Maana
9.166 Manthan Software Services
9.167 MapD Technologies
9.168 MapR Technologies
9.169 MariaDB Corporation
9.170 MarkLogic Corporation
9.171 Mathworks
9.172 Melissa
9.173 MemSQL
9.174 Metric Insights
9.175 Microsoft Corporation
9.176 MicroStrategy
9.177 Minitab
9.178 MongoDB
9.179 Mu Sigma
9.180 NEC Corporation
9.181 Neo4j
9.182 NetApp
9.183 Nimbix
9.184 Nokia
9.185 NTT Data Corporation
9.186 Numerify
9.187 NuoDB
9.188 NVIDIA Corporation
9.189 Objectivity
9.190 Oblong Industries
9.191 OpenText Corporation
9.192 Opera Solutions
9.193 Optimal Plus
9.194 Oracle Corporation
9.195 Palantir Technologies
9.196 Panasonic Corporation/Arimo
9.197 Panorama Software
9.198 Paxata
9.199 Pepperdata
9.200 Phocas Software
9.201 Pivotal Software
9.202 Prognoz
9.203 Progress Software Corporation
9.204 Provalis Research
9.205 Pure Storage
9.206 PwC (PricewaterhouseCoopers International)
9.207 Pyramid Analytics
9.208 Qlik
9.209 Qrama/Tengu
9.210 Quantum Corporation
9.211 Qubole
9.212 Rackspace
9.213 Radius Intelligence
9.214 RapidMiner
9.215 Recorded Future
9.216 Red Hat
9.217 Redis Labs
9.218 RedPoint Global
9.219 Reltio
9.220 RStudio
9.221 Rubrik/Datos IO
9.222 Ryft
9.223 Sailthru
9.224 Salesforce.com
9.225 Salient Management Company
9.226 Samsung Group
9.227 SAP
9.228 SAS Institute
9.229 ScaleOut Software
9.230 Seagate Technology
9.231 Sinequa
9.232 SiSense
9.233 Sizmek
9.234 SnapLogic
9.235 Snowflake Computing
9.236 Software AG
9.237 Splice Machine
9.238 Splunk
9.239 Strategy Companion Corporation
9.240 Stratio
9.241 Streamlio
9.242 StreamSets
9.243 Striim
9.244 Sumo Logic
9.245 Supermicro (Super Micro Computer)
9.246 Syncsort
9.247 SynerScope
9.248 SYNTASA
9.249 Tableau Software
9.250 Talend
9.251 Tamr
9.252 TARGIT
9.253 TCS (Tata Consultancy Services)
9.254 Teradata Corporation
9.255 Thales/Guavus
9.256 ThoughtSpot
9.257 TIBCO Software
9.258 Toshiba Corporation
9.259 Transwarp
9.260 Trifacta
9.261 Unifi Software
9.262 Unravel Data
9.263 VANTIQ
9.264 VMware
9.265 VoltDB
9.266 WANdisco
9.267 Waterline Data
9.268 Western Digital Corporation
9.269 WhereScape
9.270 WiPro
9.271 Wolfram Research
9.272 Workday
9.273 Xplenty
9.274 Yellowfin BI
9.275 Yseop
9.276 Zendesk
9.277 Zoomdata
9.278 Zucchetti

Chapter 10: Conclusion & Strategic Recommendations
10.1 Why is the Market Poised to Grow?
10.2 Geographic Outlook: Which Countries Offer the Highest Growth Potential?
10.3 Partnerships & M&A Activity: Highlighting the Importance of Big Data
10.4 Driving the Development of Digital Therapeutics
10.5 Improving Outcomes, Achieving Operational Efficiency and Reducing Costs
10.6 Assessing the Impact of Connected Health Solutions
10.7 Accelerating the Transition Towards Value-Based Care
10.8 The Emergence of Advanced AI (Artificial Intelligence) & Machine Learning Techniques
10.9 The Value of Big Data in Precision Medicine
10.10 Addressing Privacy & Security Concerns
10.11 The Role of Data Protection Legislation
10.12 Blockchain: Enabling Secure, Efficient and Interoperable Data Sharing
10.13 Recommendations
10.13.1 Big Data Hardware, Software & Professional Services Providers
10.13.2 Healthcare & Pharmaceutical Industry Stakeholders

For more information about this report visit https://www.researchandmarkets.com/research/ppf95c/big_data?w=5

Media Contact:


Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/big-data-investments-in-the-healthcare--pharmaceutical-industry-will-account-for-nearly-4-7-billion-in-2018-alone-300688346.html

SOURCE Research and Markets

View Comments and Join the Discussion!